Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Noncoding regions are the main source of targetable tumor-specific antigens.

Laumont CM, Vincent K, Hesnard L, Audemard É, Bonneil É, Laverdure JP, Gendron P, Courcelles M, Hardy MP, Côté C, Durette C, St-Pierre C, Benhammadi M, Lanoix J, Vobecky S, Haddad E, Lemieux S, Thibault P, Perreault C.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau5516. doi: 10.1126/scitranslmed.aau5516.

PMID:
30518613
2.

Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods.

Lanoix J, Durette C, Courcelles M, Cossette É, Comtois-Marotte S, Hardy MP, Côté C, Perreault C, Thibault P.

Proteomics. 2018 Jun;18(12):e1700251. doi: 10.1002/pmic.201700251. Epub 2018 Apr 24.

PMID:
29508533
3.

MHC class I-associated peptides derive from selective regions of the human genome.

Pearson H, Daouda T, Granados DP, Durette C, Bonneil E, Courcelles M, Rodenbrock A, Laverdure JP, Côté C, Mader S, Lemieux S, Thibault P, Perreault C.

J Clin Invest. 2016 Dec 1;126(12):4690-4701. doi: 10.1172/JCI88590. Epub 2016 Nov 14.

4.

SUMO-Modification of the La Protein Facilitates Binding to mRNA In Vitro and in Cells.

Kota V, Sommer G, Durette C, Thibault P, van Niekerk EA, Twiss JL, Heise T.

PLoS One. 2016 May 25;11(5):e0156365. doi: 10.1371/journal.pone.0156365. eCollection 2016.

5.

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.

Granados DP, Rodenbrock A, Laverdure JP, Côté C, Caron-Lizotte O, Carli C, Pearson H, Janelle V, Durette C, Bonneil E, Roy DC, Delisle JS, Lemieux S, Thibault P, Perreault C.

Leukemia. 2016 Jun;30(6):1344-54. doi: 10.1038/leu.2016.22. Epub 2016 Feb 9.

PMID:
26857467
6.

Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.

Laumont CM, Daouda T, Laverdure JP, Bonneil É, Caron-Lizotte O, Hardy MP, Granados DP, Durette C, Lemieux S, Thibault P, Perreault C.

Nat Commun. 2016 Jan 5;7:10238. doi: 10.1038/ncomms10238.

7.

Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling.

Lamoliatte F, Caron D, Durette C, Mahrouche L, Maroui MA, Caron-Lizotte O, Bonneil E, Chelbi-Alix MK, Thibault P.

Nat Commun. 2014 Nov 13;5:5409. doi: 10.1038/ncomms6409.

PMID:
25391492
8.

Regulation of stress-inducible phosphoprotein 1 nuclear retention by protein inhibitor of activated STAT PIAS1.

Soares IN, Caetano FA, Pinder J, Rodrigues BR, Beraldo FH, Ostapchenko VG, Durette C, Pereira GS, Lopes MH, Queiroz-Hazarbassanov N, Cunha IW, Sanematsu PI, Suzuki S, Bleggi-Torres LF, Schild-Poulter C, Thibault P, Dellaire G, Martins VR, Prado VF, Prado MA.

Mol Cell Proteomics. 2013 Nov;12(11):3253-70. doi: 10.1074/mcp.M113.031005. Epub 2013 Aug 12.

9.

Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.

Lamoliatte F, Bonneil E, Durette C, Caron-Lizotte O, Wildemann D, Zerweck J, Wenshuk H, Thibault P.

Mol Cell Proteomics. 2013 Sep;12(9):2536-50. doi: 10.1074/mcp.M112.025569. Epub 2013 Jun 7.

10.

Role of SUMOylation in full antiestrogenicity.

Hilmi K, Hussein N, Mendoza-Sanchez R, El-Ezzy M, Ismail H, Durette C, Bail M, Rozendaal MJ, Bouvier M, Thibault P, Gleason JL, Mader S.

Mol Cell Biol. 2012 Oct;32(19):3823-37. doi: 10.1128/MCB.00290-12. Epub 2012 Jul 23.

11.

Structure of the Rtt109-AcCoA/Vps75 complex and implications for chaperone-mediated histone acetylation.

Tang Y, Holbert MA, Delgoshaie N, Wurtele H, Guillemette B, Meeth K, Yuan H, Drogaris P, Lee EH, Durette C, Thibault P, Verreault A, Cole PA, Marmorstein R.

Structure. 2011 Feb 9;19(2):221-31. doi: 10.1016/j.str.2010.12.012. Epub 2011 Jan 20.

12.

Long-term outcomes in adults with chronic ITP after splenectomy failure.

McMillan R, Durette C.

Blood. 2004 Aug 15;104(4):956-60. Epub 2004 Apr 20.

Supplemental Content

Loading ...
Support Center